Wednesday, January 28, 2009

Immelt Stakes His Legacy on GE’s Ability to Keep Dividend, Aaa

I know it's never going to happen, but Jeff Immelt should be given a medal for standing up for long-time, loyal, shareholders. By not cutting the dividend even though he is under immense pressure from Wall Street and malicious speculators to do so, Immelt is displaying enormous courage and leadership values rarely seen in wimpy corporate execs these days.

In contrast, Pfizer's weasle CEO, Jeffrey Kindle, decided to punish loyal, longtime shareholders by cutting the dividend in half even though the company's balance sheet is far less stressed than that of GE's. He spit in the eye of so many who have stood by Pfizer for so long and nothing but a lame excuse for his actions.

If you are a Pfizer shareholder, as I am, voice your unhappiness with Mr. Kindle.

No comments: